Bleeding News and Research

RSS

Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis

Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

2 Jun 2011

Nighttime heart and lung transplants do not affect patient survival

Despite concerns that surgeon fatigue is leading to dangerous complications for patients and data showing worse outcomes for many patients who undergo surgery at night, new Johns Hopkins research suggests that — in the case of heart and lung transplants — time of day has no affect on patient survival.

1 Jun 2011

Bowel cancer strikes early - strikes hard

Recent figures show that the incidence of bowel cancer in young people has surged in the past decade, more than doubling in some age categories. But doctors have been unable to explain the increase.

1 Jun 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

Over 9 out of every 10 women giving birth in the United States had some complication in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

27 May 2011

Research sheds light on how painkillers could prevent or slow down cancer growth

CANCER RESEARCH UK scientists have shed light on how a common class of painkillers - which includes ibuprofen - may interact with a key protein that fuels the growth of many different types of cancer, according to a study published in the journal Chemical Communications today.

27 May 2011

Omega-3 fatty acids reduce risk of heart attack in stent patients

Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

27 May 2011

Transarterial embolization an effective alternative to endoscopy for acute peptic ulcer bleeding

Researchers from China report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe procedure which reduces the need for surgery without increasing overall mortality and is associated with few complications.

24 May 2011

Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS

Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.

24 May 2011

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

24 May 2011

New FIGO classification system benefits women with AUB

Abnormal uterine bleeding in women of reproductive age may be due to a wide range of disorders or pathologies. Until now, there has been no universally accepted method for classifying such patients, which has impeded basic science and clinical investigation, as well as the practical, rational, and consistent application of medical and surgical therapy.

21 May 2011

Court documents offer details of administration's legal defense of individual mandate

The federal government offered an aggressive defense of the new health law in a reply brief filed Wednesday in the multi-state challenge to the overhaul.

20 May 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

CSL-Behring recombinant factor research presented

Advances that CSL Behring is making in developing innovative new technologies to meet the unmet therapeutic needs of patients with hemophilia A and B will be the topic of an oral presentation at an international medical congress on May 22, 2011. CSL Behring is a global biotherapeutics company specializing in plasma-derived and recombinant therapies and is a subsidiary of CSL Limited (ASX:CSL).

19 May 2011

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Use of a simple, at-home screening test by Canadians can prevent many unnecessary colorectal cancer deaths, according to a special report about colorectal cancer in Canadian Cancer Statistics 2011 released today by the Canadian Cancer Society, in collaboration with the Public Health Agency of Canada and Statistics Canada.

19 May 2011

Pregnant women warned not to eat for two: Study

According to health experts, there is a “life-long obesity risk of 'eating for two' in pregnancy”. The common advice is reinforced by the results of a study that followed women for a number of years.

19 May 2011

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

The University of Washington Center for Commercialization and Pharmigene, a leader in advancing personalized medicine and reducing severe adverse reactions to drugs through genetic-based diagnostic solutions, today announced the execution of a licensing agreement between the parties.

18 May 2011

CryoLife acquires Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation.

17 May 2011

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Jessica and Chad Browning were ecstatic last fall when they learned they were expecting twins. They had two children already, but wanted a third to round out their family. Twins were a bonus.

16 May 2011

Bleeding News and Research

Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis

Nighttime heart and lung transplants do not affect patient survival

Bowel cancer strikes early - strikes hard

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

Research sheds light on how painkillers could prevent or slow down cancer growth

Omega-3 fatty acids reduce risk of heart attack in stent patients

Transarterial embolization an effective alternative to endoscopy for acute peptic ulcer bleeding

Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

New FIGO classification system benefits women with AUB

Court documents offer details of administration's legal defense of individual mandate

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

CSL-Behring recombinant factor research presented

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Pregnant women warned not to eat for two: Study

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

CryoLife acquires Cardiogenesis

First fetoscopic laser procedure to correct Twin-Twin Transfusion syndrome performed in Dallas

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News